Taking Truvada to Prevent H.I.V. Also Comes With Risks - New York Times

Such a pill has long been a goal of research, something that might help stem a global epidemic that is still causing two million new worldwide cases each year, including 50,000 in the United States. But the panel members worried about how to ...

Panel recommends approving Truvada to prevent HIV infection - CNN

(CNN)-- A drug already approved for treatment of AIDS might one day be approved for prevention of the deadly disease in individuals at high risk. A U.S. Food and Drug Administration advisory committee recommended Thursday that the agency approve ...

Truvada for HIV prevention backed by advisory panel, FDA may decide by June - CBS News

(CBS/AP) In a landmark decision, an advisory panel to the Food and Drug Administration voted to recommend approval of Truvada to prevent HIV infection. The FDA is not required to the follow the panel of experts' advice, though it typically does.

Panel Recommends Approving Truvada To Prevent HIV - San Diego Channel

(CNN) -- A drug already approved for treatment of AIDS might one day be approved for prevention of the deadly disease in individuals at high risk. A Food and Drug Administration advisory committee recommended Thursday that the agency approve the ...

FDA ADAC recommends approval of Gilead’s Truvada for HIV - News-Medical.Net

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) has voted to support approval of once-daily oral Truvada ® (emtricitabine and tenofovir disoproxil ...

FDA Panel OKs Truvada as First HIV-Preventive Drug - WebMD

May 10, 2012 -- An FDA advisory panel today recommended approval of the drug Truvada to prevent the spread of HIV infection in high-risk, healthy people. Since 2004, the drug has been been approved to treat people already infected with HIV, the ...

FDA panel recommendation sets Gilead's Truvada on course to be first HIV preventative - The Business Journal

Gilead Sciences Inc.'s Gilead Sciences Inc. Latest from The Business Journals R&D credits taken, even by a company long gone FDA panel backs Gilead's four drugs-in-one HIV tablet Gilead’s Truvada on course to be first HIV preventative Follow this company ...

Gilead Sciences’ HIV Drugs Clear a Hurdle - Investorplace.com

A U.S. government advisory panel recommended approval of Quad, the company’s experimental four-in-one HIV drug, and the off-label use of Truvada, an existing drug, to prevent HIV infections. The down side? Gilead derives nearly 75% of its ...

Should the FDA approve Big Pharma marketing drug treatments to healthy people? - Natural News.com

If approved, Gilead Sciences will be able to market Truvada to anyone who might be considered "at risk" for contracting the disease based on lifestyle and other factors (such as sexual orientation). Normally, HIV-infected patients take Truvada to slow viral replication.

US health experts back approval of the HIV drug Truvada for daily use - Jamaica Gleaner

A panel of United States health experts has for the first time backed a drug to prevent HIV infection in healthy people. The Antiviral Drugs Advisory Committee voted 19 to 3 in favour of recommending that US regulators approve the daily tablet, Truvada for ...